Business
CollPlant's rhCollagen-Based BioInk Demonstrates Strong Performance Compared to Matrigel® in Study Conducted by Technion - Israel Institute of Technology
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen), today announced positive results from a head-to-head comparative study of its rhCollagen-based bioink, Collink.3D™, and Matrigel®, conducted by the Levenberg Lab at Technion - Israel Institute of Technology.
About this update from Corning Incorporated
[{"type":"list","items":[{"val":[{"type":"text","content":"A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D™, outperformed Matrigel®, a leading extracellular matrix, in supporting structured tissue formation.","length":209,"tagName":"p"}]},{"val":[{"type":"text","content":"The findings suggest Collink.3D™ could offer a consistent, tunable, and animal-free alternative for advanced tissue engineering and research applications.","length":154,"tagName":"p"}]},{"val":[{"type":"text","content":"Extracellular matrices are key tools in drug discovery, regenerative medicine, and tissue modeling. CollPlant's plant-based technology provides a sustainable and ethical approach without compromising performance.","length":216,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":579,"olType":false},{"type":"text","content":"REHOVOT, Israel, Oct. 20, 2025 /PRNewswire/ -- CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies and products based on its proprietary recombinant human collagen (rhCollagen), today announced positive results from a head-to-head comparative study of its rhCollagen-based bioink, Collink.3D™, and Matrigel®, conducted by the Levenberg Lab at Technion - Israel Institute of Technology.","length":456,"tagName":"p"},{"type":"image","alt":"Collink.3D (left image) exhibited skeletal Muscle elongation while Matrigel (right image) appeared non-uniform on day 7 (Technion)","displaySize":"","headline":null,"caption":"Collink.3D (left image) exhibited skeletal Muscle elongation while Matrigel (right image) appeared non-uniform on day 7 (Technion)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":196,"url":"https://media.zenfs.com/en/prnewswire.com/f6b78f41766e2115698eac1e909a1957"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/R71FgnqVxuKsF17S2bl9sg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTM0NTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/f6b78f41766e2115698eac1e909a1957","width":400,"height":196}},"href":"https://mma.prnewswire.com/media/2800257/CollPlant_Photo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Matrigel®, developed and marketed by Corning, has been one of the most widely used extracellular matrices for more than three decades. Derived from the...